Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Treatment with mesenchymal stem cells (MSCs) is a new promising therapeutic approach with substantial very auspicious potential. They have been shown to protect various played a role in protecting organs from damage. This current study aims to evaluate the impact of the treatment of olive leaf extract (OLE), bone marrow‐derived (BM‐MSCs), and their combination on hepatotoxicity in pregnant rats with diabetes. Methods: Animals were divided into five groups (10 pregnant rats each) as follows: control, GDM group, and OLE group (rats received streptozotocin (STZ) at a dose of 35 mg/kg body weight). GD + OLE set (pregnant rats were administered OLE at a dose of 200 mg extract/kg of body weight). GD + MSCs group (pregnant rats treated with MSCs). GD + OLE + MSCs group (pregnant rats were treated with both MSCs and OLE). Results: STZ induced significant changes in liver parameters, lipid profile, and oxidative stress. Treatment with OLE, BM‐MSCs, and their combination significantly ameliorated STZ‐induced liver damage and oxidative stress. STZ resulted in a significant change in liver parameters, lipid profile, and oxidative stress. OLE, BM‐MSC, and combination have significantly improved STZ‐induced deterioration in liver and improved oxidative stress. Conclusions: The findings demonstrate that OLE and BM‐MSCs have beneficial effects in mitigating diabetes‐related liver alterations. These outcomes showed that OLE and BM‐MSC have beneficial effects in alleviating diabetes‐related alterations in the liver.
Treatment with mesenchymal stem cells (MSCs) is a new promising therapeutic approach with substantial very auspicious potential. They have been shown to protect various played a role in protecting organs from damage. This current study aims to evaluate the impact of the treatment of olive leaf extract (OLE), bone marrow‐derived (BM‐MSCs), and their combination on hepatotoxicity in pregnant rats with diabetes. Methods: Animals were divided into five groups (10 pregnant rats each) as follows: control, GDM group, and OLE group (rats received streptozotocin (STZ) at a dose of 35 mg/kg body weight). GD + OLE set (pregnant rats were administered OLE at a dose of 200 mg extract/kg of body weight). GD + MSCs group (pregnant rats treated with MSCs). GD + OLE + MSCs group (pregnant rats were treated with both MSCs and OLE). Results: STZ induced significant changes in liver parameters, lipid profile, and oxidative stress. Treatment with OLE, BM‐MSCs, and their combination significantly ameliorated STZ‐induced liver damage and oxidative stress. STZ resulted in a significant change in liver parameters, lipid profile, and oxidative stress. OLE, BM‐MSC, and combination have significantly improved STZ‐induced deterioration in liver and improved oxidative stress. Conclusions: The findings demonstrate that OLE and BM‐MSCs have beneficial effects in mitigating diabetes‐related liver alterations. These outcomes showed that OLE and BM‐MSC have beneficial effects in alleviating diabetes‐related alterations in the liver.
Yara iyileşme süreci, klinik uygulamada birtakım zorluklarla seyreden uzun bir süreç olup güncel tedavilerin etkileri halen sınırlıdır. Yara iyileşme süreci, hücrelerin göçü ve proliferasyonu, ekstraselüler matriksin yeniden şekillendirilmesi ve anjiyogenez ile ilişkilidir. Çeşitli risk faktörleri, kronik iltihaplanma ve bazı hastalıklar, yetersiz yara kapanmasına yol açarak fibrozisle sonuçlanabilecek bir yara izi oluşmasına neden olabilir. Son yıllarda, mezenkimal kök hücrelerin (MKH) yara iyileşmesi ve cilt yenilenmesi üzerinde güçlü terapötik potansiyele sahip olduğuna dair kanıtlar ortaya çıkmıştır. Ancak, MKH'lerin doğrudan uygulanmasında hala birçok sorunla karşılaşılmaktadır. Bununla birlikte son yıllarda, köken aldığı hücrelerden belirli bileşenler içeren lipid çift tabakalı membran yapısına sahip ve “granüler veziküller” olarak tanımlanan eksozomlar, MKH'ler için mükemmel bir alternatif olarak ortaya çıkmıştır. Çeşitli çalışmalarda özellikle MKH'lerden türetilen eksozomların (MKHE) yaraların iyileşmesi ve cilt rejenerasyonu için faydalı olduğu gösterilmiştir. Eksozomların cilt yaralarını iyileştirme sürecinde etkili olduğu mekanizmalar arasında inflamasyonu hafifletmek, damar oluşumunu uyarmak, epitel hücreleri ve fibroblastların proliferasyon ve göçünü uyarmak yer almaktadır. Bu nedenle, MKHE uygulanması, cilt yaralarının tedavisinde hücre tedavisine umut verici bir alternatif olabilir ve aynı anda birden fazla mekanizma aracılığıyla yara iyileşmesini teşvik edebilir. Bu derlemede, MKH'lerden türetilen eksozomların yara iyileşmesinde ve cilt rejenerasyonundaki rolü ve mekanizmaları hakkında güncel bilgiler sunulacak ve MKHE’lerin klinik uygulamalardaki potansiyelleri ayrıntılı olarak ele alınacaktır.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.